Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Avantika Barve"'
Autor:
Martin Metz, MD, Jonathan A. Bernstein, MD, Ana M. Giménez-Arnau, MD, PhD, Michihiro Hide, MD, PhD, Marcus Maurer, MD, Karl Sitz, MD, Weily Soong, MD, Gordon Sussman, MD, Eva Hua, MSc, Avantika Barve, PhD, Nathalie Barbier, MSc, Maria-Magdalena Balp, MD, Thomas Severin, MD
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 11, Pp 100716- (2022)
Background: Disease burden is particularly high in Chronic Spontaneous Urticaria (CSU) patients with angioedema, and patients whose signs and symptoms are inadequately controlled by H1-antihistamines need new treatment options. Here we report an expl
Externí odkaz:
https://doaj.org/article/a5accb64ff364949badf84c3169fe9b9
Autor:
Sinisa Savic, I V Danilycheva, Alis Burciu, Avantika Barve, Ana Giménez-Arnau, Petra Staubach, Karl Sitz, Thomas Severin, Chia-Yu Chu, Michael Makris, Gordon Sussman, Jonathan A. Bernstein, Martin Metz, Marcus Maurer, Michihiro Hide, Eva Hua, Reinhold Janocha, Weily Soong
Background: Ligelizumab, a next-generation, humanized anti-immunoglobulin E (IgE) monoclonal antibody is in development as a treatment for patients with chronic spontaneous urticaria, whose symptoms are inadequately controlled with standard-of-care t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c23593f71df398bcdf2c73e22822a6a4
Autor:
Martin Metz, Jonathan A. Bernstein, Ana M. Giménez-Arnau, Michihiro Hide, Marcus Maurer, Karl Sitz, Weily Soong, Gordon Sussman, Eva Hua, Avantika Barve, Nathalie Barbier, Maria-Magdalena Balp, Thomas Severin
Background: Disease burden is particularly high in Chronic Spontaneous Urticaria (CSU) patients with angioedema, and patients whose signs and symptoms are inadequately controlled by H1-antihistamines need new treatment options. Here we report an expl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e848a9a11c0ae32a763c7938e1857c8b
https://publica.fraunhofer.de/handle/publica/442486
https://publica.fraunhofer.de/handle/publica/442486
Autor:
Luis Felipe Ensina, Jonathan Bernstein, Gordon Sussman, Marcus Maurer, Ana Maria Giménez-Arnau, Sarabjit Saini, Vineeth Varanasi, Avantika Barve, Eva Hua, Manmath Patekar, Thomas Severin
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB130
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c9173e3125f30222b1b867511c63c05
https://doi.org/10.1016/j.jaci.2022.12.410
https://doi.org/10.1016/j.jaci.2022.12.410
Autor:
Clive Grattan, Bettina Wedi, Wen-Hung Chung, Petra Staubach, R. Y. Meshkova, Karl Sitz, Sinisa Savic, Ana M Gimenez-Arnau, Gordon L Sussman, Randolf Brehler, I V Danilycheva, Kenneth Kobayashi, Jacques Hébert, Jonathan A. Bernstein, Chia-Yu Chu, Rodney Sinclair, Martin Metz, Jurgen Loffler, Michael Makris, Thomas Severin, Diane Baker, Reinhold Janocha, Andrea Bauer, Constance H. Katelaris, Eva Hua, Marcus Maurer, Avantika Barve
Publikováno v:
New England Journal of Medicine. 381:1321-1332
Background: In the majority of patients with chronic spontaneous urticaria, most currently available therapies do not result in complete symptom control. Ligelizumab is a next-generation high-affinity humanized monoclonal anti-IgE antibody. Data are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63ae7b977e1f79ac75bb2374b6e8afeb
https://doi.org/10.1056/nejmoa1900408
https://doi.org/10.1056/nejmoa1900408
Autor:
Marcus Maurer, Weily Soong, Janocha Reinhold, Jonathan A. Bernstein, Ana Giménez-Arnau, Karl Sitz, Eva Hua, Thomas Severin, Nathalie Barbier, Avantika Barve, Audrey Lamirand
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A356-A357
Introduction Dans l’etude de phase 2b principale ( NCT02477332 ), le ligelizumab a presente une reponse dose-dependante en termes de controle complet de l’urticaire (score HSS7 = 0) a la semaine 12 (critere primaire) et a obtenu un meilleur contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df97e62e5fd5ee8a359583cbfa0d6dab
https://doi.org/10.1016/j.fander.2021.09.431
https://doi.org/10.1016/j.fander.2021.09.431
Autor:
Marcus Maurer, Avantika Barve, Maria-Magdalena Balp, Thomas Severin, Nathalie Barbier, Weily Soong, Ana Giménez-Arnau, Audrey Lamirand, Janocha Reinhold, Martin Metz, Jonathan A. Bernstein
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A357-A358
Introduction Les scores Urticaria Activity Score (UAS) et Dermatology Life Quality Index (DLQI) sont des evaluations renseignees par le patient et utilisees pour evaluer l’activite de l’urticaire chronique spontanee (UCS) et son impact sur la qua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12d7eade27d8d6f078a9dd16c10b8e6a
https://doi.org/10.1016/j.fander.2021.09.433
https://doi.org/10.1016/j.fander.2021.09.433
Publikováno v:
The Journal of Clinical Pharmacology. 60
Oral contraceptives (OCs) are the most widely used form of birth control among women of childbearing potential. Knowledge of potential drug-drug interactions (DDIs) with OCs becomes imperative to provide information on the medication to women of chil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::669dfb491716aa8f144f22fe0ff0cbc3
https://doi.org/10.1002/jcph.1765
https://doi.org/10.1002/jcph.1765
Autor:
Catherine L. Jones, Surendra Machineni, Avantika Barve, Stephen Youngberg, Erin Brandt, Richard Colvin, Kristina Dabovic, Christopher T. Jones
Publikováno v:
Journal of Drug Assessment
Objective: Infection with hepatitis C virus is the leading indication for liver transplantation and most common cause of infectious disease-related mortality in the United States. BZF961 is a novel inhibitor of the hepatitis C virus NS3-4A protease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db9c5dea9be4497cf9079718b3641260
http://europepmc.org/articles/PMC6201795
http://europepmc.org/articles/PMC6201795
Autor:
Nathalie Barbier, Weily Soong, Thomas Severin, Eva Hua, Karl Sitz, Reinhold Janocha, Avantika Barve, Ana Giménez-Arnau, Jonathan A. Bernstein, Marcus Maurer
Publikováno v:
Journal of the American Academy of Dermatology. 85:AB137
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a45124c82fb49cfad45efaf7931b5ca
https://doi.org/10.1016/j.jaad.2021.06.564
https://doi.org/10.1016/j.jaad.2021.06.564